Paris, France

Jean Kadouche

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean Kadouche

Introduction

Jean Kadouche is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of eight patents to his name, Kadouche's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents are innovative constructs related to multispecific antigens binding fragments and multispecific antibodies. One of his inventions involves multispecific antibody constructs comprising Fab fragments that have mutations at the interface of the CH1 and CL domains. These mutations are designed to prevent heavy chain/light chain mispairing, enhancing the efficacy of the antibodies. Another patent focuses on similar constructs, further demonstrating his expertise in this specialized area of research.

Career Highlights

Throughout his career, Jean Kadouche has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Lausanne. His experience in these organizations has allowed him to collaborate with leading scientists and contribute to groundbreaking research in the field of immunology.

Collaborations

Kadouche has had the opportunity to work alongside notable colleagues, including Jean-Pierre Mach and Olivier Michielin. Their collaborative efforts have further advanced the understanding and application of multispecific antibodies in therapeutic settings.

Conclusion

Jean Kadouche's innovative work in the field of biotechnology, particularly in the development of multispecific antibodies, showcases his significant contributions to science. His patents and collaborations reflect a commitment to advancing medical research and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…